PPARG and glioma: Pioglitazone-induced inhibition of glioma cell proliferation and invasion occurred in a PPAR-γ-dependent manner and is in agreement with its ability to dramatically reduce β-catenin expression and transcriptional activity, resulting in decreased cell proliferation, migration, and apoptosis.